menu
    • menu

    Find Atezolizumab manufacturers, exporters & distributors on PharmaCompass

    NEW Prospects: 104
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    3

    API Suppliers

    1

    USDMF

    0

    CEP/COS

    0

    JDMF

    0

    EU WC

    0

    KDMF

    0

    NDC API

    0

    VMF

    2

    Listed Suppliers

    0INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    FINISHED DOSAGE FORMULATIONS

    93

    FDF Dossiers

    3

    FDA Orange Book

    33

    Europe

    3

    Canada

    48

    Australia

    6

    South Africa

    0

    Listed Dossiers

    104PROSPECTS

    510DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    0RELATED EXCIPIENT COMPANIES

    0EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    9

    Health Canada Patents
    API/FDF Prices: Book a Demo

    API REF. PRICE (USD/KG)

    $
    $ 0

    GLOBAL SALES INFORMATION

    US Medicaid

    28,732,491

    Annual Reports

    22,288

    Regulatory FDF Prices

    NA

    MARKET PLACE

    2

    API

    1

    FDF

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    352

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Annual Reports

    read-more
    read-more

    01

    Brand Name : Tecentriq

    Atezolizumab

    arrow
    ChemTides
    Not Confirmed

    Brand Name : Tecentriq

    Switzerland
    arrow
    ChemTides
    Not Confirmed

    Roche

    Atezolizumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2019 Revenue in Millions : 1,931

    2018 Revenue in Millions : 795

    Growth (%) : 143

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Tecentriq

    Atezolizumab

    arrow
    ChemTides
    Not Confirmed

    Brand Name : Tecentriq

    Switzerland
    arrow
    ChemTides
    Not Confirmed

    Roche

    Atezolizumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2020 Revenue in Millions : 3,051

    2019 Revenue in Millions : 2,089

    Growth (%) : 46

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Tecentriq

    Atezolizumab

    arrow
    ChemTides
    Not Confirmed

    Brand Name : Tecentriq

    Switzerland
    arrow
    ChemTides
    Not Confirmed

    Roche

    Atezolizumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 3,568

    2020 Revenue in Millions : 2,902

    Growth (%) : 21

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Tecentriq

    Atezolizumab

    arrow
    ChemTides
    Not Confirmed

    Brand Name : Tecentriq

    Switzerland
    arrow
    ChemTides
    Not Confirmed

    Roche

    Atezolizumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 4,063

    2021 Revenue in Millions : 3,568

    Growth (%) : 14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Tecentriq

    Atezolizumab

    arrow
    ChemTides
    Not Confirmed

    Brand Name : Tecentriq

    Switzerland
    arrow
    ChemTides
    Not Confirmed

    Roche

    Atezolizumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 4,369

    2022 Revenue in Millions : 4,063

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Tecentriq

    Atezolizumab

    arrow
    ChemTides
    Not Confirmed

    Brand Name : Tecentriq

    Switzerland
    arrow
    ChemTides
    Not Confirmed

    Roche

    Atezolizumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2024 Revenue in Millions : 4,010

    2023 Revenue in Millions : 4,369

    Growth (%) : -8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Tecentriq

    Atezolizumab

    arrow
    ChemTides
    Not Confirmed

    Brand Name : Tecentriq

    Switzerland
    arrow
    ChemTides
    Not Confirmed

    Roche

    Atezolizumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2017 Revenue in Millions : 516

    2016 Revenue in Millions : 166

    Growth (%) : 210

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Tecentriq

    Atezolizumab

    arrow
    ChemTides
    Not Confirmed

    Brand Name : Tecentriq

    Switzerland
    arrow
    ChemTides
    Not Confirmed

    Roche

    Atezolizumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2018 Revenue in Millions : 780

    2017 Revenue in Millions : 492

    Growth (%) : 59%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search